Odyssey
  • Homepage
  • Objectives
  • News
  • Publications
  • Contact
  • Restricted
Select Page

IAS 2019 – Oral abstract on ODYSSEY PK study presented at conference in Mexico City

by Communication Team | Jul 30, 2019 | ODYSSEY

IAS 2019 – Oral abstract on ODYSSEY PK study presented at conference in Mexico City We are delighted to report that a late breaker oral presentation on the key PK substudy nested within the ODYSSEY trial was accepted and presented at the 10th IAS Conference on...

Recent Posts

  • Dolutegravir for Children living with HIV
  • ODYSSEY trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children.
  • What does COVID-19 mean for those living in HIV communities?
  • ODYSSEY trial: COVID-19 response and CROI update
  • Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years

Recent Comments

    Archives

    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • August 2019
    • July 2019
    • March 2019
    • July 2018
    • June 2018
    • April 2018
    • August 2017
    • September 2016

    Categories

    • ODYSSEY
    • Publication

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    This study is funded by ViiV Healthcare and the sponsor is PENTA Foundation